Victory Capital Management
RUBY

Victory Capital Management’s Rubius Therapeutics, Inc RUBY Stock Holding History

Victory Capital Management’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,932,248
Closed -$16.2M – 2770
2022
Q1 		$16.2M Buy
2,932,248
+489,248
+20% +$3.11M 0.02% 964
2021
Q4 		$23.6M Buy
2,443,000
+631,892
+35% +$8.76M 0.02% 857
2021
Q3 		$32.4M Buy
1,811,108
+238,921
+15% +$5.2M 0.03% 702
2021
Q2 		$38.4M Buy
1,572,187
+371,370
+31% +$9.29M 0.04% 661
2021
Q1 		$31.8M Buy
+1,200,817
New +$17.5M 0.03% 737
2020
Q2 		– Sell
-6,082
Closed -$28K – 3510
2020
Q1 		$28K Buy
+6,082
New +$45.2K ﹤0.01% 2994
2019
Q4 		– Sell
-4,606
Closed -$36K – 3495
2019
Q3 		$36K Buy
+4,606
New +$53.7K ﹤0.01% 2828

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $235M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return